AXQ Capital’s Royalty Pharma RPRX Stock Holding History

AXQ Capital’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$638K	Sell	11,373 -12,353	-52%	-$643K	0.07%	409
2026 Q1	$1.14M	Buy	23,726 +11,528	+95%	+$505K	0.15%	215
2025 Q4	$471K	Buy	+12,198	New	+$465K	0.11%	310
2024 Q2	–	Sell	-7,900	Closed	-$240K	–	686
2024 Q1	$240K	Buy	+7,900	New	+$233K	0.06%	475
2023 Q2	–	Sell	-6,000	Closed	-$216K	–	521
2023 Q1	$216K	Buy	+6,000	New	+$222K	0.09%	392

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

AXQ Capital's RPRX Position: Q2 2026 in Review

AXQ Capital reduced its Royalty Pharma (RPRX) stake by 52% in Q2 2026, selling an estimated $643K and leaving 11,373 shares worth $638K. The position accounts for 0.07% of the portfolio, ranked #409.

AXQ Capital first reported a position in RPRX in Q1 2023 and has held it in 5 quarters since. The position peaked at $1.14M in Q1 2026. 645 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

AXQ Capital held 11,373 shares of Royalty Pharma worth $638K as of Q2 2026.
AXQ Capital sold 12,353 Royalty Pharma shares in Q2 2026, an estimated $643K.
Royalty Pharma made up 0.07% of AXQ Capital's portfolio in Q2 2026, its #409 holding.
AXQ Capital first reported a position in Royalty Pharma in Q1 2023 and has held it in 5 quarters since.
AXQ Capital's Royalty Pharma position peaked at $1.14M in Q1 2026.
645 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on AXQ Capital's 13F filing for Q2 2026, filed 6 Aug 2026.